CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | May/June 2020

An Interview With Mayra Guerrero, MD

Dr. Guerrero offers insight on the effects of COVID-19 at her cath lab, an update on the status of the MITRAL trial, her role promoting greater female representation among interventional cardiologists, and more.

cit | Article | September/October 2018

CT Assessment Before TMVR

Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD, and Marco Barbanti, MD

cit | Article | July/August 2015

Techniques for Percutaneous Left Ventricular Apical Access

What you need to know.

By Mayra Guerrero, MD; Amit Pursnani, MD; Mike Salinger, MD; Justin Levisay, MD; Paul Pearson, MD; and Ted E. Feldman, MD

cit | Article | July/August 2016

Transcatheter Valve Implantation for Calcific Mitral Stenosis

TMVR with aortic THV devices might evolve into an acceptable alternative for selected patients with severe mitral annular calcification.

By Mayra Guerrero, MD; Dee Dee Wang, MD; Amit Pursnani, MD; Adam Greenbaum, MD; Michael Salinger, MD; Marvin Eng, MD; William O'Neill, MD; and Ted E. Feldman, MD

Advertisement

Advertisement

cit | Article | March/April 2015

Early Experience With Transcatheter Mitral Valve Replacement

The current status of this novel technique to treat patients with severe mitral disease who are not candidates for surgery.

By Mayra Guerrero, MD, FACC, FSCAI; Adam B. Greenbaum, MD, FACC, FSCAI; and William O'Neill, MD, FACC, FSCAI

cit | Article | May/June 2013

Understanding Imaging to Assess the Aortic Annulus for TAVR

A review of imaging for annulus size assessment for transcatheter aortic valve replacement.

By Paul T. Vaitkus, MD, MBA, and Mayra Guerrero, MD

cit | News | July 10, 2016

MITRAL Investigates TMVR in Native Mitral Valve Disease With Severe Mitral Annular Calcification

July 10, 2016—Results from the MITRAL multicenter global registry were published by Mayra Guerrero, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2016;9:1361–1371).

cit | News | April 22, 2018

Outcomes Evaluated for TMVR Patients With Severe Mitral Annular Calcification

April 23, 2018—Findings from an evaluation of 1-year outcomes of transcatheter mitral valve replacement (TMVR) in patients with severe mitral annular calcification (MAC) were published by Mayra Guerrero, MD, et al in Journal of the American College of Cardiology (JACC; 2018;71:1841–1853).

cit | Article | July/August 2015

Structural Disease Update

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | September/October 2018

Challenging Cases: What Would You Do?

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Shakeel A. Qureshi, MD, FRCP, FRCPCH

cit | News | October 21, 2018

Findings Published From Initial Cases With Neovasc's Tiara TMVR Device

October 22, 2018—Neovasc Inc. announced the publication of findings from the initial experiences of transcatheter mitral valve replacement (TMVR) using the company's Tiara valve in patients with previous aortic valve replacement.

cit | Article | July/August 2016

Mitral Technology & Lesion Assessment

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | May/June 2013

Options in PCI and AMI

By Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | March/April 2015

THV Expansion

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | May/June 2020

STEMI in Focus; Structural Imaging

By Salvatore Brugaletta, MD; Dee Dee Wang, MD; and Edwin Ho, MD

cit | News | October 27, 2025

ENCIRCLE Evaluates Edwards Sapien M3 TMVR System for MR Reduction

October 27, 2025—Results from the ENCIRCLE pivotal clinical trial demonstrated effective reduction of mitral regurgitation (MR) with low rates of complications and mortality using a fully percutaneous transseptal mitral valve replacement (TMVR) procedure in patients with symptomatic, moderate-to-severe MR who are not candidates for conventional surgery or transcatheter edge-to-edge repair procedures.

cit | News | December 23, 2025

Edwards Sapien M3 Transseptal TMVR System Approved by FDA

December 23, 2025—Edwards Lifesciences announced FDA approval for the company’s Sapien M3 transcatheter mitral valve replacement (TMVR) system as a transseptal therapy for the treatment of mitral regurgitation (MR).


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button